Symptoms were assessed over 3 years in patients with primary knee OA receiving strontium ranelate 2 g/day ( n = 454 ) , 1 g/day ( n = 445 ) or placebo ( n = 472 ) in the Strontium Ranelate Efficacy in Knee Osteoarthritis Trial .